APLS FY 2015 Earnings — Apellis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

APLSApellis Pharmaceuticals, Inc.

$2B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$47M

Net Income

-$47M

EPS (Diluted)

$-2.57

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$545,701

Balance Sheet

Total Assets

$38M

Total Liabilities

$3M

Stockholders' Equity

$35M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$47M	-$11M	-312.4%
Net Income	-$47M	-$11M	-331.2%